Bristol-Myers Squibb Co. (BMY) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $57.62 -1.61%
EPS Growth %: +10.3%
Financial Fact:
Net Sales: 4.92B
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: +10.3%
Financial Fact:
Net Sales: 4.92B
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q2 EPS of $0.48, $0.01 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $4.44 billion versus the consensus estimate of $4.44 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers
- Trump's annual disclosures show $236 million in crypto proceeds, gifts worth $370,000
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
